The booming companion cancer diagnostics market, valued at $15 billion in 2025, is projected to grow at a robust CAGR, driven by personalized medicine and advanced technologies like NGS. Discover key market trends, regional insights, and leading companies shaping this dynamic sector. Explore the impact of liquid biopsies and other innovative diagnostic tools on cancer treatment and patient outcomes.

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.